Healthcare

ENDP shares surge on rare good news but asset sales may still be necessary.
Failure to hold the $210 area could mean a deeper decline to $180 is possible.
The objective message of the market on Biogen is that selling actions are no longer indicated, and buying actions are.
The strategy doesn't deserve a lot of the criticism it gets.
Even if its deal with Cigna doesn't go through, the insurer still has good opportunities to pursue.
Barring a strong rally over $31 that has follow-through, we look for AZN to slowly erode.
GSK has been largely stuck between $44 on the upside and $37 on the downside for the past 12 months.
Yellen caught flak for her biotech call -- but called it right.
Prices pop today, but is this a reversal?
A new low down at $80 might be just enough weakness to prompt further declines.

Columnist Conversations

A breakout is underway on the weekly chart of the New York Times Company (NYT) with shares penetrating a ...
NOC is very soft today.  The aerospace/defense company is off over 1.5% as selling pressure picks up.&nbs...
There is far too much complacency in the financial markets. We are at the opposite end of the investor sentime...
we waited for this name to move and today it is robust, on good turnover and call action.  We are going t...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.